Atomoxetine (Strattera)
About Atomoxetine (Strattera)
Atomoxetine (Strattera) is a selective norepinephrine reuptake inhibitor. Strattera is the first and only non-stimulant medication approved by the US Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults.Unlike stimulants (such as Ritalin or Concerta) which are believed to reduce ADHD symptoms through their impact on the availability of dopamine in the central nervous system, Strattera is believed to have effects upon the central nervous system neurotransmitter norepinephrine, a brain chemical considered important in regulating attention, impulsivity and activity levels.
Strattera comes in capsule form, and current recommended dosing is once or twice daily
On September 29, 2005, the FDA directed Eli Lilly and Company, the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional warning statements that alert health care providers of an increased risk of suicidal thinking in children and adolescents being treated with this medication.
Usual Side Effects
- Difficulty sleeping
- Loss of appetite
- Irritability
- Nervousness
- Stomach aches
- Headaches
- Dry mouth
- Blurry vision
- Nausea
Rare Side Effects
- Suicidal thoughts
- Liver damage
- Decreased growth/li>
- Hives
- Cardiac arrhythmia
- Psychosis
- Jaundice
Dosages
Strattera and Tourette Syndrome
Personal expierence
If you have any experience with Atomoxetine (Strattera) please register (its free), Login and add to this blog by posting a comment below. You must login to post a comment